Gene Query: NCAPG

Dataset Description Geneva Score
Genome-wide transcriptional response to random aneuploidy in human cells 119.13
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 102.93
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 101.15
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 97.27
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 79.24
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 66.36
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 66.27
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 63.51
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 56.8
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 55.33
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 54.96
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 54.96
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 54.47
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 53.59
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 53.43
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 47.77
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 47.58
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 46.11
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 45.81
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 45.09
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 44.72
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 44.67
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 44.18
Transcriptional profiles of normal human mature B cells 43.77
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 43.64
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 43.64
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 42.4
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 42.4
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 41.34
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 40.63
Identification of global regulators of T-helper cell lineage specification 40.63
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 40.49
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 40.35
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 40.35
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 39.81
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 38.6
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 38.21
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 37.7
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 37.61
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 37.61
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 36.57
RNA-seq of resting and activated CD4+ T cells +-JQ1 35.76
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 35.18
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 35.12
Role for citron kinase in prostate cancer growth 34.87
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 34.38
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 33.82
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 33.57
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 33.45
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 33.34
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 33.34
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 33.03
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 33.03
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 32.62
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 32.55
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 32.54
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 32.46
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 32.28
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 32.23
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 32.21
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 32.21
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 32.18
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 31.75
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 30.72
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 30.68
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 30.52
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 30.31
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 30.13
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 30.01
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 30.01
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 29.87
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 29.7
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 29.56
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 29.17
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 29.12
A Unique Epigenomic Landscape Defines Human Erythropoiesis 28.68
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 28.68
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 28.54
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 28.48
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 28.44
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 28.42
Human cell line and subcutaneous tumor 28.41
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 28.32
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 28.32
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 28.16
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 27.97
The regulartory role of ZCCHC24 in splicing machinery 27.96
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 27.67
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 27.0
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 26.98
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 26.98
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 26.98
Disruption of the exocyst induces podocyte loss and dysfunction 26.84
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 26.82
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 26.71
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 26.62
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 26.53
Gene expression changes caused by KRAS in MCF-10A 26.25
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 25.95
Transcription control by the ENL YEATS domain in acute leukemia 25.93
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 25.93
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 25.93
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 25.61
Landscape of H3K4me3 in human CD19 cells 25.56
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 25.5
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 25.45
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 25.05
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 25.04
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 24.81
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 24.76
The landscape of alternative splicing in aggressive prostate cancers 24.65
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 24.33
IRF2 is a master regulator of human keratinocyte stem cell fate 24.33
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 24.33
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 24.29
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 24.23
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 24.23
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 24.22
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 24.18
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 24.18
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 24.13
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 24.0
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 23.65
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 23.46
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 23.45
Expression level comparison under dividing and quiescent states in human primary fibroblasts 23.42
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 23.31
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 23.31
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 23.31
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 23.27
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 23.16
Effect of CHKA knockdown on C4-2 cell transcriptome 23.14
Zika infected neural stem cells 23.11
Transcriptome analysis of Zika infected neural stem cells 23.11
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 22.98
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 22.91
LncRNA-GAS5 negative regulation of YAP-target genes expression 22.87
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 22.83
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 22.83
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 22.81
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 22.79
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 22.78
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 22.47
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 22.37
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 22.22
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 22.22
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 22.11
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 22.05
Expression profiling of etoposide-induced senescent cells 22.03
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 22.03
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 21.84
Transcriptional responses of human insulinoma cells to acute cytokine exposure 21.77
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 21.7
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 21.69
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 21.67
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 21.67
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 21.31
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 21.2
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 21.2
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 21.2
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 20.91
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 20.75
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 20.65
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 20.52
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 20.41
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 20.41
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 20.29
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 20.11
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 20.11
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 20.09
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 20.06
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 20.02
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 19.93
Widespread intronic polyadenylation diversifies immune cell transcriptomes 19.81
A code of mono-phosphorylation modulates the function of RB. 19.77
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 19.74
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 19.71
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 19.57
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 19.46
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 19.37
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 19.23
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 19.14
MYCi361 regulates MYC target genes 19.12
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 19.09
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 18.84
Genome-wide analysis of Dengue virus 2 infected cells 18.82
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 18.82
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 18.73
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 18.73
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 18.7
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 18.66
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 18.64
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 18.6
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 18.59
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 18.52
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 18.52
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 18.36
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 18.3
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 18.25
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 18.19
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 18.16
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 18.11
Overexpression and knockdown experiment for circCSNK1G3 18.05
Ribosomal footprinting of CN34-Parental and CN34-LM1a 17.96
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 17.96
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 17.96
A sister of NANOG regulates genes expressed in pre-implantation human development 17.84
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 17.73
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 17.64
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 17.62
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 17.62
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 17.62
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 17.57
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 17.48
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 17.42
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 17.42
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 17.42
Short and Long RNA sequencing of human mature erythrocytes 17.42
3’ Uridylation Expands miRNA Target Repertoire 17.35
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 17.3
Ribosomal footprinting of MDA-Parental and MDA-LM2 17.25
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 17.24
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 17.24
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 17.23
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 17.15
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 17.14
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 17.12
TGF-β regulation of miRNA expression in pancreatic cancer 17.12
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 17.07
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 17.06
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 17.01
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 16.92
RNA-seq analysis to identify the genes regulated by p53-SET interplay 16.88
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 16.88
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 16.87
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 16.84
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 16.79
A549 cells and MSR-A549 cells 16.79
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 16.62
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 16.6
Molecular Mechanisms of Endothelial Hyperpermeability 16.58
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 16.54
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 16.53
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 16.51
Differentially expressed vascular development genes for iPSC-ECs from CDI 16.36
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 16.34
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 16.34
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 16.27
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 16.17
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 15.99
Regulation of highly expressed hCINAP on translatome 15.99
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 15.96
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 15.92
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  15.74
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 15.7
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 15.66
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 15.57
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 15.54
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 15.46
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 15.44
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 15.4
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 15.34
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 15.34
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 15.31
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 15.28
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 15.28
TOP2B disturbed the quality of human oocytes with advanced maternal age 15.27
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 15.26
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 15.26
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 15.23
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 15.23
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 15.23
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 15.23
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 15.12
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 15.08
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 15.03
Co-regulation of splicing by Rbfox1 and hnRNP M 15.03
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 15.0
p63 controls the enhancer landscape during keratinocyte differentiation 14.92
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 14.91
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 14.86
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 14.74
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 14.66
Identification of HOXB13 target genes responsive to BET inhibitors 14.62
Identification of differentially expressed genes between senescence and senescence bypass cells 14.61
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 14.57
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 14.55
Gene expression profiling of human and murine in vitro muscle differentiation 14.54
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 14.42
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 14.37
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 14.33
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 14.32
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 14.31
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 14.29
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 14.22
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 14.21
RNAseq Study in CC-671 Treated Cal-51 Cells 14.07
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 14.07
Global analyses of the effect of different cellular contexts on microRNA targeting 14.06
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 14.06
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 14.06
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 13.98
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 13.95
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 13.8
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 13.78
hnRNP C is a key regulator of protein synthesis in mitosis 13.46
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 13.45
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 13.43
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 13.41
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 13.4
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 13.4
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 13.39
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 13.27
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 13.26
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 13.17
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 13.17
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 13.13
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 13.13
Fbxo32 mediated gene expression program underlies EMT and metastasis 12.98
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 12.94
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 12.79
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 12.66
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 12.6
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 12.43
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 12.43
Ro60-knockout cells 11.96
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 11.95
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 11.93
Integrin signaling regulates YAP/TAZ to control skin homeostasis 11.89
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 11.87
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 11.81
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 11.81
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 11.79
MCF10A H-Ras RNA-Seq 11.62
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 11.62
Transcriptome of U251 cells overexpression complement component 7 11.52
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 11.51
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 11.46
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 11.46
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 11.43
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 11.4
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 11.4
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 11.37
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 11.34
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 11.33
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 10.96
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 10.87
A novel target of EZH1/2 for treatment of mantle cell lymphoma 10.84
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 10.75
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 10.71
Effect of from Human Umbilical Vein Endothelial Cells 10.59
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 10.57
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 10.52
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 10.5
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 10.5
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 10.26
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 10.16
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 10.16
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 10.11
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 10.11
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 10.09
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 10.09
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 10.01
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 10.01
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 10.01
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 9.94
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 9.91
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 9.78
Be1 and Be2 B cells are transcriptionally distinct 9.76
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 9.7
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 9.7
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 9.67
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 9.42
TAF1 is critical for AE driven leukemogenesis 9.37
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 9.37
Human cells contain natural double-stranded RNAs with potential regulatory capacity 9.21
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 9.04
JunB control of keratinocyte-mediated inflammation [RNA-seq] 9.04
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 9.01
Bone marrow derived human B cells [normal proB] 8.92
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 8.83
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 8.58
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 8.52
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 8.52
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 8.43
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 8.35
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 8.28
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 8.24
The Genetic Landscape of Diamond-Blackfan Anemia 8.09
Targeting MTHFD2 in Acute Myeloid Leukemia 7.91
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 7.72
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.69
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 7.69
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 7.17
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 7.01
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 7.01
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.92
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.92
Entrectinib Resistance in a Neuroblastoma Xenograft Model 6.82
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 6.8
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 6.8
The contribution of Alu exons to the human proteome 6.64
6mer seed toxicity in tumour suppressive microRNAs 6.53
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.53
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.47
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 6.41
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 6.36
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 6.3
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 6.3
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 6.23
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 5.99
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 5.99
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 5.98
RNA-Seq of PRMT1 overexpression ECA109 cells 5.91
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 5.91
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 5.79
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 5.54
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 5.47
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 5.42
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 5.41
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 5.41
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 5.24
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.09
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.09
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 5.08
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 5.03
Identification of Sin3B regulated genes during quiescence 5.02
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 4.96
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 4.92
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 4.81
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 4.46
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 4.36
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 4.36
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 4.36
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 4.28
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 4.22
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 4.12
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 4.11
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.94
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.89
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.56
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 3.48
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 3.47
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 3.47
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.46
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.44
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 3.39
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 3.28
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 3.28
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 3.28
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 3.23
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 3.23
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.19
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.16
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.14
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.0
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.0
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 2.62
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 2.62
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 2.62
RNA-seq analysis upon ARID1B overexpression 2.6
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.53
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.53
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.52
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.41
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 2.36
The circadian transcriptional landscape in primary human mammary epithelial cells 2.33
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 2.32
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.31
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.26
Gene expression profile of CRC-derived HILEC 2.2
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.14
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 2.07
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 1.91
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.88
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 1.87
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 1.87
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.81
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.6
6mer seed toxicity in viral microRNAs 1.49
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.47
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.45
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.4
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.26
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.09
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.98
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.98
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.92
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.78
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.76
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.73
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.71
Modulation of nonsense-mediated decay by rapamycin 0.65
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.55
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.52
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.52
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.52
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.49
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.4
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.36


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation